SCHEMBL22155671

SCHEMBL22155671

CC(O)CCn1cnc2ccc(Br)cc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 1/20 0.43
FABP4 P15090 1/20 0.41
TDP1 Q9NUW8 1/20 0.40
MTNR1A P48039 1/20 0.40
MTNR1B P49286 1/20 0.40
GLP1R P43220 1/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
IDO1 P14902 1/20 0.39
POLB P06746 1/20 0.38
EGFR P00533 2/20 0.37
LMNA P02545 2/20 0.37
APAF1 O14727 1/20 0.37
BRD4 O60885 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
EGLN3 Q9H6Z9 1/20 0.36
GGPS1 O95749 1/20 0.36
FDPS P14324 1/20 0.36
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17263174 0.81 TDP1 (0.44) MCL1TDP1MTNR1AMTNR1BNPC1
SCHEMBL29463886 0.81 TDP1 (0.44) MCL1TDP1MTNR1AMTNR1BNPC1
SCHEMBL1528531 0.80 POLB (0.59) MCL1FABP4TDP1GLP1RNPC1
SCHEMBL15205675 0.79 HDAC1 (0.47) MCL1TDP1MTNR1AMTNR1BNPC1
SCHEMBL15272387 0.79 LMNA (0.60) TDP1NPC1RAB9AEGFRLMNA
SCHEMBL6174975 0.78 TDP1 (0.68) TDP1POLBLMNAAPAF1EGLN3
SCHEMBL483805 0.78 TDP1 (0.44) MCL1FABP4TDP1MTNR1AMTNR1B
SCHEMBL1940039 0.78 NPC1 (0.52) MCL1FABP4TDP1GLP1RNPC1
SCHEMBL17678284 0.78 EGFR (0.56) FABP4TDP1MTNR1AMTNR1BNPC1
SCHEMBL5695836 0.78 MEN1 (0.61) TDP1MTNR1AMTNR1BGLP1RNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200197391-A1 COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF Revolution Medicines, Inc. 2020-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200197391-A1 COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF KRAS, NRAS, HRAS MCL1 29/4885FABP4 2088/4885TDP1 2779/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.